Seres Therapeutics Inc.

NASDAQ: MCRB · Real-Time Price · USD
9.60
1.18 (14.01%)
At close: Jun 25, 2025, 3:42 PM
14.01%
Bid 9.45
Market Cap 83.87M
Revenue (ttm) n/a
Net Income (ttm) 72.95M
EPS (ttm) -7.95
PE Ratio (ttm) -1.21
Forward PE -0.93
Analyst Hold
Ask 9.77
Volume 176,077
Avg. Volume (20D) 98,854
Open 8.34
Previous Close 8.42
Day's Range 8.16 - 9.77
52-Week Range 6.53 - 30.60
Beta 2.62

About MCRB

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MCRB
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MCRB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 month ago
-16.04%
Seres Therapeutics shares are trading lower after ... Unlock content with Pro Subscription
6 months ago
+3.83%
Seres Therapeutics shares are trading higher after the company announced that SER-155 received FDA breakthrough therapy designation for its bloodstream infection reduction.